Pharmacokinetics of Topical SB204 in Adolescents With Acne Vulgaris

NCT02801903 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Acne Vulgaris

Interventions

DRUG: SB204 4%

Sponsor

Novan, Inc.

Collaborators

[object Object]